Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $66.15M.
ENTERPRISE VALUE (EV)
$66.15M
Cardiff Oncology, Inc.
Market Cap
$83.62M
Enterprise Value (EV)
$66.15M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | $83.62M | $66.15M |
| Citius Oncology, Inc. (CTOR)vs › | $83.66M | $77.31M |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | $43.52M |
| LENSAR Inc (LNSR)vs › | $82.59M | $71.41M |
| MediciNova, Inc. (MNOV)vs › | $82.45M | $57.15M |
| Humacyte, Inc. (HUMA)vs › | $84.25M | $70.53M |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.48M | $31.05M |
| Nutriband Inc. (NTRB)vs › | $82.07M | $78.84M |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.98M | $51.48M |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.36M | $93.02M |
Market Cap
$83.62M
Total Debt
$0.00
Cash
$17.47M
Enterprise Value
$66.15M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
